Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.60742121 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.33108411 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.00963320 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.00963320 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.70416967 |
6 | NIK/NF-kappaB signaling (GO:0038061) | 4.80979535 |
7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.73925664 |
8 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.61220874 |
9 | positive regulation of B cell differentiation (GO:0045579) | 4.52753843 |
10 | B cell receptor signaling pathway (GO:0050853) | 4.51065971 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22371174 |
12 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.03147014 |
13 | nuclear pore complex assembly (GO:0051292) | 3.97807644 |
14 | response to interleukin-15 (GO:0070672) | 3.95353774 |
15 | regulation of B cell differentiation (GO:0045577) | 3.91585792 |
16 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.87633021 |
17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.85100909 |
18 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.78170709 |
19 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.66012512 |
20 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.62469480 |
21 | positive thymic T cell selection (GO:0045059) | 3.59638309 |
22 | negative thymic T cell selection (GO:0045060) | 3.51421450 |
23 | T cell lineage commitment (GO:0002360) | 3.50605056 |
24 | positive regulation of histone deacetylation (GO:0031065) | 3.49286185 |
25 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43263505 |
26 | hepatocyte apoptotic process (GO:0097284) | 3.43129145 |
27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.39177220 |
28 | negative regulation of cell killing (GO:0031342) | 3.39177220 |
29 | natural killer cell differentiation (GO:0001779) | 3.38220003 |
30 | megakaryocyte development (GO:0035855) | 3.35274234 |
31 | negative T cell selection (GO:0043383) | 3.34463215 |
32 | B cell mediated immunity (GO:0019724) | 3.33583879 |
33 | growth hormone receptor signaling pathway (GO:0060396) | 3.31374739 |
34 | germinal center formation (GO:0002467) | 3.25509056 |
35 | response to peptidoglycan (GO:0032494) | 3.25140050 |
36 | nuclear pore organization (GO:0006999) | 3.23294492 |
37 | cellular response to interleukin-15 (GO:0071350) | 3.21780489 |
38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.19850984 |
39 | modulation by symbiont of host defense response (GO:0052031) | 3.19850984 |
40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.19850984 |
41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.19850984 |
42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.19850984 |
43 | modulation by symbiont of host immune response (GO:0052553) | 3.19850984 |
44 | thymic T cell selection (GO:0045061) | 3.12119615 |
45 | response to type I interferon (GO:0034340) | 3.11686424 |
46 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.08025589 |
47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06155592 |
48 | mature B cell differentiation (GO:0002335) | 3.04689372 |
49 | positive regulation of interferon-alpha production (GO:0032727) | 3.04093589 |
50 | type I interferon signaling pathway (GO:0060337) | 3.04010226 |
51 | cellular response to type I interferon (GO:0071357) | 3.04010226 |
52 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.03433706 |
53 | T cell selection (GO:0045058) | 3.01719842 |
54 | pore complex assembly (GO:0046931) | 3.01543044 |
55 | T cell proliferation (GO:0042098) | 3.00610791 |
56 | DNA unwinding involved in DNA replication (GO:0006268) | 2.98643004 |
57 | myeloid dendritic cell differentiation (GO:0043011) | 2.98104110 |
58 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.97242598 |
59 | regulation of chromatin binding (GO:0035561) | 2.96149464 |
60 | lymph node development (GO:0048535) | 2.94607109 |
61 | Peyers patch development (GO:0048541) | 2.94382533 |
62 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.94382533 |
63 | T cell migration (GO:0072678) | 2.93871842 |
64 | detection of bacterium (GO:0016045) | 2.92891028 |
65 | regulation of interferon-alpha production (GO:0032647) | 2.89512872 |
66 | regulation of antigen processing and presentation (GO:0002577) | 2.89236693 |
67 | regulation of histone H3-K27 methylation (GO:0061085) | 2.89166928 |
68 | embryonic hemopoiesis (GO:0035162) | 2.88997213 |
69 | immunoglobulin mediated immune response (GO:0016064) | 2.87372579 |
70 | cellular response to growth hormone stimulus (GO:0071378) | 2.87330088 |
71 | response to muramyl dipeptide (GO:0032495) | 2.85853197 |
72 | myeloid dendritic cell activation (GO:0001773) | 2.85549788 |
73 | B cell proliferation (GO:0042100) | 2.85461607 |
74 | T cell homeostasis (GO:0043029) | 2.82166696 |
75 | detection of other organism (GO:0098543) | 2.80329664 |
76 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80106275 |
77 | defense response to protozoan (GO:0042832) | 2.79118609 |
78 | lymphocyte homeostasis (GO:0002260) | 2.76393771 |
79 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.75996124 |
80 | histone H3-K36 demethylation (GO:0070544) | 2.72740010 |
81 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.72126911 |
82 | positive regulation of Rap GTPase activity (GO:0032854) | 2.71298812 |
83 | B cell homeostasis (GO:0001782) | 2.70062459 |
84 | response to protozoan (GO:0001562) | 2.67384591 |
85 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.66711938 |
86 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.65564762 |
87 | DNA topological change (GO:0006265) | 2.65227163 |
88 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.65058175 |
89 | activated T cell proliferation (GO:0050798) | 2.64199827 |
90 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62377696 |
91 | dosage compensation (GO:0007549) | 2.62310802 |
92 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.62118003 |
93 | regulation of regulatory T cell differentiation (GO:0045589) | 2.62020531 |
94 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.61200128 |
95 | positive regulation of interleukin-12 production (GO:0032735) | 2.61084520 |
96 | positive T cell selection (GO:0043368) | 2.60459078 |
97 | dendritic cell chemotaxis (GO:0002407) | 2.60162613 |
98 | regulation of B cell proliferation (GO:0030888) | 2.60152663 |
99 | formation of translation preinitiation complex (GO:0001731) | 2.59274645 |
100 | mitotic chromosome condensation (GO:0007076) | 2.59141531 |
101 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.59061481 |
102 | pinocytosis (GO:0006907) | 2.58857306 |
103 | DNA duplex unwinding (GO:0032508) | 2.58573467 |
104 | snRNA metabolic process (GO:0016073) | 2.58394091 |
105 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.58141452 |
106 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.57965840 |
107 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.57691995 |
108 | cellular response to interleukin-4 (GO:0071353) | 2.56831338 |
109 | regulation of translational fidelity (GO:0006450) | 2.56649468 |
110 | negative regulation of B cell proliferation (GO:0030889) | 2.56598672 |
111 | dendritic cell differentiation (GO:0097028) | 2.56568184 |
112 | regulation of natural killer cell differentiation (GO:0032823) | 2.56352062 |
113 | cellular hyperosmotic response (GO:0071474) | 2.55572713 |
114 | JAK-STAT cascade (GO:0007259) | 2.54032931 |
115 | histone H3-K4 trimethylation (GO:0080182) | 2.53899694 |
116 | lymphocyte proliferation (GO:0046651) | 2.53497028 |
117 | mononuclear cell proliferation (GO:0032943) | 2.53157870 |
118 | cellular response to interferon-beta (GO:0035458) | 2.52724291 |
119 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.51031652 |
120 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.51031652 |
121 | regulation of erythrocyte differentiation (GO:0045646) | 2.49351215 |
122 | ribosomal small subunit biogenesis (GO:0042274) | 2.49239715 |
123 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.49172649 |
124 | positive regulation of antigen processing and presentation (GO:0002579) | 2.48552151 |
125 | definitive hemopoiesis (GO:0060216) | 2.48304408 |
126 | negative regulation of histone methylation (GO:0031061) | 2.48186954 |
127 | DNA geometric change (GO:0032392) | 2.48075450 |
128 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.47964955 |
129 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.47964955 |
130 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.47914911 |
131 | positive regulation of interleukin-2 production (GO:0032743) | 2.47829328 |
132 | cellular response to interferon-gamma (GO:0071346) | 2.47506203 |
133 | positive regulation of interferon-beta production (GO:0032728) | 2.46778208 |
134 | T cell costimulation (GO:0031295) | 2.46776082 |
135 | regulation of necroptotic process (GO:0060544) | 2.45463344 |
136 | positive regulation of B cell activation (GO:0050871) | 2.43741399 |
137 | leukocyte homeostasis (GO:0001776) | 2.43131075 |
138 | lymphocyte costimulation (GO:0031294) | 2.42524713 |
139 | snRNA processing (GO:0016180) | 2.42168967 |
140 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.40356459 |
141 | positive regulation of natural killer cell activation (GO:0032816) | 2.39567216 |
142 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.39349200 |
143 | leukocyte proliferation (GO:0070661) | 2.38605052 |
144 | response to interferon-beta (GO:0035456) | 2.35926601 |
145 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.35203210 |
146 | RNA stabilization (GO:0043489) | 2.30723451 |
147 | mRNA stabilization (GO:0048255) | 2.30723451 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.28790713 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.27525510 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.59273048 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.58756026 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.95358181 |
6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.40769117 |
7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.30707665 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.14635433 |
9 | MYC_22102868_ChIP-Seq_BL_Human | 3.13083318 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.02119887 |
11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.01551225 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99087411 |
13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.94311144 |
14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82512519 |
15 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.78237153 |
16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.78095663 |
17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.65356455 |
18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.61660358 |
19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.57402688 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48896434 |
21 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.46720623 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.40935259 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 2.36317183 |
24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.32493686 |
25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.27862636 |
26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27796002 |
27 | * MAF_26560356_Chip-Seq_TH1_Human | 2.20790215 |
28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19797048 |
29 | * MYB_26560356_Chip-Seq_TH2_Human | 2.17127891 |
30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12886336 |
31 | * MYB_26560356_Chip-Seq_TH1_Human | 2.12599169 |
32 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.12005263 |
33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.08015973 |
34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.05973108 |
35 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02348253 |
36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.86070789 |
37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.86052615 |
38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.85420369 |
39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84789693 |
40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83079201 |
41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.82301035 |
42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78752284 |
43 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.76568850 |
44 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.75455383 |
45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.70816847 |
46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69843255 |
47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.66670584 |
48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65477770 |
49 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.65009496 |
50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.64737899 |
51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.62255771 |
52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60769341 |
53 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58384698 |
54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54132089 |
55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.53854971 |
56 | * MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.52518892 |
57 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.52272422 |
58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51136456 |
59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.49332350 |
60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48782402 |
61 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44867223 |
62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.43303559 |
63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41544544 |
64 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41186093 |
65 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.41074734 |
66 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.40183923 |
67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.37986452 |
68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36938684 |
69 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36290404 |
70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35986831 |
71 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.35151433 |
72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33630020 |
73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.31972834 |
74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30387539 |
75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28868182 |
76 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28526101 |
77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27919977 |
78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.27060071 |
79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26509471 |
80 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25082023 |
81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24095729 |
82 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23303252 |
83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22116327 |
84 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.16601107 |
85 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.15638731 |
86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14762511 |
87 | MAF_26560356_Chip-Seq_TH2_Human | 1.14388767 |
88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14269283 |
89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13178681 |
90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.12869537 |
91 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12678143 |
92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11320008 |
93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11047230 |
94 | GATA3_26560356_Chip-Seq_TH2_Human | 1.10889724 |
95 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09830664 |
96 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07190760 |
97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07174395 |
98 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.04830189 |
99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03399937 |
100 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01442187 |
101 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01211055 |
102 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.00967970 |
103 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00759129 |
104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00579069 |
105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00239613 |
106 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99963719 |
107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98476005 |
108 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97892781 |
109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97139948 |
110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96995791 |
111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96979274 |
112 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.96832431 |
113 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95786216 |
114 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95717548 |
115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95415283 |
116 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.95247492 |
117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94840204 |
118 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.93319683 |
119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92627371 |
120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91333598 |
121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91154674 |
122 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.90580788 |
123 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89736920 |
124 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87487986 |
125 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85898917 |
126 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85088165 |
127 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.83486485 |
128 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83116881 |
129 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 0.83002033 |
130 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.82519626 |
131 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81887388 |
132 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81885662 |
133 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77838068 |
134 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77258872 |
135 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76169489 |
136 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74931964 |
137 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74645011 |
138 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72512210 |
139 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.70943744 |
140 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.70166599 |
141 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.69596474 |
142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67297257 |
143 | TP53_16413492_ChIP-PET_HCT116_Human | 0.67290773 |
144 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.65989526 |
145 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62982213 |
146 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.62581145 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0001835_abnormal_antigen_presentation | 4.28814132 |
2 | MP0000685_abnormal_immune_system | 3.72460069 |
3 | * MP0001800_abnormal_humoral_immune | 3.42361393 |
4 | MP0001790_abnormal_immune_system | 3.34815357 |
5 | MP0005387_immune_system_phenotype | 3.34815357 |
6 | MP0002254_reproductive_system_inflammat | 3.27482559 |
7 | MP0004510_myositis | 3.21548338 |
8 | MP0005671_abnormal_response_to | 2.90749732 |
9 | MP0008057_abnormal_DNA_replication | 2.84622428 |
10 | * MP0002452_abnormal_antigen_presenting | 2.72536482 |
11 | MP0001873_stomach_inflammation | 2.65282036 |
12 | MP0005000_abnormal_immune_tolerance | 2.65046333 |
13 | MP0003300_gastrointestinal_ulcer | 2.58109171 |
14 | MP0002396_abnormal_hematopoietic_system | 2.50219155 |
15 | MP0000569_abnormal_digit_pigmentation | 2.49667027 |
16 | * MP0002723_abnormal_immune_serum | 2.49343573 |
17 | MP0003303_peritoneal_inflammation | 2.48200407 |
18 | MP0003436_decreased_susceptibility_to | 2.39143075 |
19 | MP0010094_abnormal_chromosome_stability | 2.38326936 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.33748136 |
21 | MP0003763_abnormal_thymus_physiology | 2.32359120 |
22 | MP0002398_abnormal_bone_marrow | 2.32004859 |
23 | * MP0001819_abnormal_immune_cell | 2.31594193 |
24 | MP0002166_altered_tumor_susceptibility | 2.30107985 |
25 | MP0003111_abnormal_nucleus_morphology | 2.24398113 |
26 | MP0004808_abnormal_hematopoietic_stem | 2.20143773 |
27 | * MP0000716_abnormal_immune_system | 2.11947598 |
28 | MP0005025_abnormal_response_to | 2.10191064 |
29 | MP0002138_abnormal_hepatobiliary_system | 1.98075191 |
30 | MP0003077_abnormal_cell_cycle | 1.96428415 |
31 | MP0010155_abnormal_intestine_physiology | 1.94830933 |
32 | MP0009785_altered_susceptibility_to | 1.93608032 |
33 | MP0005310_abnormal_salivary_gland | 1.92981012 |
34 | MP0002877_abnormal_melanocyte_morpholog | 1.92292551 |
35 | MP0005464_abnormal_platelet_physiology | 1.91879993 |
36 | * MP0002419_abnormal_innate_immunity | 1.90682270 |
37 | MP0003183_abnormal_peptide_metabolism | 1.88949735 |
38 | MP0002148_abnormal_hypersensitivity_rea | 1.82505593 |
39 | MP0002006_tumorigenesis | 1.81473072 |
40 | MP0000689_abnormal_spleen_morphology | 1.76900543 |
41 | MP0002722_abnormal_immune_system | 1.74837102 |
42 | MP0002405_respiratory_system_inflammati | 1.73191317 |
43 | MP0009278_abnormal_bone_marrow | 1.71231616 |
44 | MP0004947_skin_inflammation | 1.70981187 |
45 | * MP0000703_abnormal_thymus_morphology | 1.69455219 |
46 | MP0005451_abnormal_body_composition | 1.69224073 |
47 | MP0003693_abnormal_embryo_hatching | 1.68556257 |
48 | * MP0002429_abnormal_blood_cell | 1.68549897 |
49 | MP0003045_fibrosis | 1.61870573 |
50 | MP0008260_abnormal_autophagy | 1.55766921 |
51 | MP0001845_abnormal_inflammatory_respons | 1.55122628 |
52 | MP0003172_abnormal_lysosome_physiology | 1.54738150 |
53 | MP0005075_abnormal_melanosome_morpholog | 1.53672114 |
54 | MP0001348_abnormal_lacrimal_gland | 1.52984818 |
55 | MP0005397_hematopoietic_system_phenotyp | 1.49321634 |
56 | MP0001545_abnormal_hematopoietic_system | 1.49321634 |
57 | MP0005174_abnormal_tail_pigmentation | 1.43603096 |
58 | MP0010352_gastrointestinal_tract_polyps | 1.35878459 |
59 | MP0006082_CNS_inflammation | 1.34909999 |
60 | MP0010234_abnormal_vibrissa_follicle | 1.34761753 |
61 | MP0003787_abnormal_imprinting | 1.30933392 |
62 | MP0000313_abnormal_cell_death | 1.26306949 |
63 | MP0000350_abnormal_cell_proliferation | 1.25591354 |
64 | MP0003866_abnormal_defecation | 1.24827149 |
65 | MP0008961_abnormal_basal_metabolism | 1.24244479 |
66 | MP0004381_abnormal_hair_follicle | 1.23765330 |
67 | MP0000465_gastrointestinal_hemorrhage | 1.21922005 |
68 | MP0005076_abnormal_cell_differentiation | 1.19165827 |
69 | MP0001853_heart_inflammation | 1.16731526 |
70 | MP0009333_abnormal_splenocyte_physiolog | 1.15254570 |
71 | MP0004957_abnormal_blastocyst_morpholog | 1.14566985 |
72 | MP0002693_abnormal_pancreas_physiology | 1.14547346 |
73 | MP0004264_abnormal_extraembryonic_tissu | 1.08982363 |
74 | MP0003724_increased_susceptibility_to | 1.08379351 |
75 | MP0008007_abnormal_cellular_replicative | 1.07636760 |
76 | MP0001730_embryonic_growth_arrest | 1.07411578 |
77 | MP0001533_abnormal_skeleton_physiology | 1.02295047 |
78 | MP0008469_abnormal_protein_level | 1.00679238 |
79 | MP0005621_abnormal_cell_physiology | 0.99670399 |
80 | MP0002928_abnormal_bile_duct | 0.98401027 |
81 | MP0003191_abnormal_cellular_cholesterol | 0.96488570 |
82 | MP0003091_abnormal_cell_migration | 0.96081481 |
83 | MP0004185_abnormal_adipocyte_glucose | 0.91346514 |
84 | MP0001661_extended_life_span | 0.90103004 |
85 | MP0002009_preneoplasia | 0.89777583 |
86 | MP0001851_eye_inflammation | 0.88028483 |
87 | MP0003453_abnormal_keratinocyte_physiol | 0.84591358 |
88 | MP0003566_abnormal_cell_adhesion | 0.82709167 |
89 | MP0001849_ear_inflammation | 0.80263803 |
90 | MP0000490_abnormal_crypts_of | 0.79511487 |
91 | MP0003984_embryonic_growth_retardation | 0.79408515 |
92 | MP0005380_embryogenesis_phenotype | 0.79248448 |
93 | MP0001672_abnormal_embryogenesis/_devel | 0.79248448 |
94 | MP0008058_abnormal_DNA_repair | 0.78869656 |
95 | MP0002088_abnormal_embryonic_growth/wei | 0.78795766 |
96 | MP0003868_abnormal_feces_composition | 0.78518860 |
97 | MP0002080_prenatal_lethality | 0.78444957 |
98 | MP0001944_abnormal_pancreas_morphology | 0.77605831 |
99 | MP0002933_joint_inflammation | 0.77437221 |
100 | MP0009764_decreased_sensitivity_to | 0.76136122 |
101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.75930382 |
102 | MP0003786_premature_aging | 0.75755637 |
103 | MP0005384_cellular_phenotype | 0.75407968 |
104 | MP0001879_abnormal_lymphatic_vessel | 0.73863151 |
105 | MP0002095_abnormal_skin_pigmentation | 0.72453373 |
106 | MP0003656_abnormal_erythrocyte_physiolo | 0.71302973 |
107 | MP0009763_increased_sensitivity_to | 0.70146599 |
108 | MP0001346_abnormal_lacrimal_gland | 0.69813594 |
109 | MP0008932_abnormal_embryonic_tissue | 0.69739978 |
110 | MP0006035_abnormal_mitochondrial_morpho | 0.69536621 |
111 | MP0003943_abnormal_hepatobiliary_system | 0.69513861 |
112 | MP0010307_abnormal_tumor_latency | 0.69468347 |
113 | MP0003448_altered_tumor_morphology | 0.69363868 |
114 | MP0001697_abnormal_embryo_size | 0.68708125 |
115 | MP0002019_abnormal_tumor_incidence | 0.67332393 |
116 | MP0000371_diluted_coat_color | 0.65818028 |
117 | MP0009765_abnormal_xenobiotic_induced | 0.65794970 |
118 | MP0009115_abnormal_fat_cell | 0.63389614 |
119 | MP0001663_abnormal_digestive_system | 0.62623044 |
120 | MP0000609_abnormal_liver_physiology | 0.62294652 |
121 | MP0000733_abnormal_muscle_development | 0.62031374 |
122 | MP0005334_abnormal_fat_pad | 0.61634217 |
123 | MP0002168_other_aberrant_phenotype | 0.60624826 |
124 | MP0008874_decreased_physiological_sensi | 0.60506178 |
125 | MP0003705_abnormal_hypodermis_morpholog | 0.59329562 |
126 | MP0002909_abnormal_adrenal_gland | 0.57939379 |
127 | MP0002136_abnormal_kidney_physiology | 0.57698502 |
128 | MP0000767_abnormal_smooth_muscle | 0.55395735 |
129 | MP0005058_abnormal_lysosome_morphology | 0.55121409 |
130 | MP0004130_abnormal_muscle_cell | 0.54841454 |
131 | MP0000858_altered_metastatic_potential | 0.54512254 |
132 | MP0005220_abnormal_exocrine_pancreas | 0.53021819 |
133 | MP0001270_distended_abdomen | 0.52617747 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Agammaglobulinemia (HP:0004432) | 5.44363568 |
2 | Cellulitis (HP:0100658) | 4.72721961 |
3 | Chronic otitis media (HP:0000389) | 4.50006495 |
4 | Recurrent bronchitis (HP:0002837) | 4.49267664 |
5 | Gastrointestinal stroma tumor (HP:0100723) | 4.26127263 |
6 | * Recurrent viral infections (HP:0004429) | 4.17031361 |
7 | * Recurrent fungal infections (HP:0002841) | 4.13416012 |
8 | * Colitis (HP:0002583) | 3.82659350 |
9 | Abnormality of the fingertips (HP:0001211) | 3.66663883 |
10 | * Chronic mucocutaneous candidiasis (HP:0002728) | 3.66608367 |
11 | * Recurrent cutaneous fungal infections (HP:0011370) | 3.66608367 |
12 | Eczematoid dermatitis (HP:0000976) | 3.64981508 |
13 | * Inflammation of the large intestine (HP:0002037) | 3.56316352 |
14 | * Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.48742421 |
15 | * Gastrointestinal inflammation (HP:0004386) | 3.39437394 |
16 | Nasal polyposis (HP:0100582) | 3.34265622 |
17 | Recurrent bacterial skin infections (HP:0005406) | 3.29306606 |
18 | Verrucae (HP:0200043) | 3.22508803 |
19 | Papilloma (HP:0012740) | 3.22508803 |
20 | Emphysema (HP:0002097) | 3.21732234 |
21 | * Meningitis (HP:0001287) | 3.21409168 |
22 | Recurrent abscess formation (HP:0002722) | 3.17470681 |
23 | Vasculitis (HP:0002633) | 3.15904553 |
24 | Lymphopenia (HP:0001888) | 3.12715870 |
25 | IgM deficiency (HP:0002850) | 3.11247879 |
26 | * Panhypogammaglobulinemia (HP:0003139) | 3.05934267 |
27 | Chronic sinusitis (HP:0011109) | 3.04617752 |
28 | Mediastinal lymphadenopathy (HP:0100721) | 3.00589915 |
29 | Interstitial pulmonary disease (HP:0006530) | 3.00020462 |
30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.97034485 |
31 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.92312078 |
32 | Recurrent sinusitis (HP:0011108) | 2.91835178 |
33 | * Recurrent skin infections (HP:0001581) | 2.88679896 |
34 | Abnormality of the nasal mucosa (HP:0000433) | 2.88032187 |
35 | Bronchitis (HP:0012387) | 2.79246424 |
36 | Periodontitis (HP:0000704) | 2.76557512 |
37 | Thrombocytosis (HP:0001894) | 2.76091284 |
38 | Osteomyelitis (HP:0002754) | 2.72178592 |
39 | Autoimmune thrombocytopenia (HP:0001973) | 2.68772147 |
40 | Granulocytopenia (HP:0001913) | 2.61777547 |
41 | Vertebral arch anomaly (HP:0008438) | 2.59484423 |
42 | Microvesicular hepatic steatosis (HP:0001414) | 2.58111038 |
43 | Prolonged bleeding time (HP:0003010) | 2.55954405 |
44 | Chronic diarrhea (HP:0002028) | 2.55252407 |
45 | Gingival bleeding (HP:0000225) | 2.52638293 |
46 | Thoracic kyphosis (HP:0002942) | 2.51073079 |
47 | * Abnormality of T cell physiology (HP:0011840) | 2.47012648 |
48 | Cutaneous melanoma (HP:0012056) | 2.43324673 |
49 | Hematochezia (HP:0002573) | 2.42925943 |
50 | Basal cell carcinoma (HP:0002671) | 2.40471552 |
51 | * Encephalitis (HP:0002383) | 2.37583020 |
52 | Restrictive lung disease (HP:0002091) | 2.37532675 |
53 | * Abnormality of T cells (HP:0002843) | 2.36055651 |
54 | Pulmonary infiltrates (HP:0002113) | 2.36017246 |
55 | Increased IgE level (HP:0003212) | 2.35577231 |
56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33896166 |
57 | Lip pit (HP:0100267) | 2.33362989 |
58 | IgA deficiency (HP:0002720) | 2.33049417 |
59 | Abnormality of the thoracic spine (HP:0100711) | 2.30583821 |
60 | Increased IgM level (HP:0003496) | 2.29865695 |
61 | Combined immunodeficiency (HP:0005387) | 2.29349460 |
62 | Persistence of primary teeth (HP:0006335) | 2.28693739 |
63 | Absent frontal sinuses (HP:0002688) | 2.28359048 |
64 | Ragged-red muscle fibers (HP:0003200) | 2.27169968 |
65 | T lymphocytopenia (HP:0005403) | 2.27121769 |
66 | Mitral stenosis (HP:0001718) | 2.26523366 |
67 | Squamous cell carcinoma (HP:0002860) | 2.26515392 |
68 | Upper motor neuron abnormality (HP:0002127) | 2.26398986 |
69 | Severe combined immunodeficiency (HP:0004430) | 2.25427675 |
70 | Abnormality of T cell number (HP:0011839) | 2.23997373 |
71 | Myositis (HP:0100614) | 2.22235827 |
72 | B lymphocytopenia (HP:0010976) | 2.20189826 |
73 | Abnormality of B cell number (HP:0010975) | 2.20189826 |
74 | Abnormality of the prostate (HP:0008775) | 2.20106420 |
75 | Epistaxis (HP:0000421) | 2.18520032 |
76 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.18493820 |
77 | Progressive external ophthalmoplegia (HP:0000590) | 2.17401524 |
78 | Asymmetry of the thorax (HP:0001555) | 2.16975944 |
79 | Acute myeloid leukemia (HP:0004808) | 2.14605969 |
80 | Urticaria (HP:0001025) | 2.11035658 |
81 | Spinal cord lesions (HP:0100561) | 2.10917418 |
82 | Syringomyelia (HP:0003396) | 2.10917418 |
83 | * Viral hepatitis (HP:0006562) | 2.10109197 |
84 | Leukopenia (HP:0001882) | 2.09293361 |
85 | Fatigue (HP:0012378) | 2.08123733 |
86 | Hypertensive crisis (HP:0100735) | 2.06462999 |
87 | Chest pain (HP:0100749) | 2.03832056 |
88 | Skin rash (HP:0000988) | 2.03804926 |
89 | Abnormality of the peritoneum (HP:0002585) | 2.02934193 |
90 | Spontaneous hematomas (HP:0007420) | 2.02177958 |
91 | IgG deficiency (HP:0004315) | 2.01814544 |
92 | Abnormal platelet function (HP:0011869) | 2.00462895 |
93 | Impaired platelet aggregation (HP:0003540) | 2.00462895 |
94 | Metaphyseal cupping (HP:0003021) | 1.98670081 |
95 | Hepatosplenomegaly (HP:0001433) | 1.98240716 |
96 | Micronodular cirrhosis (HP:0001413) | 1.97762779 |
97 | Recurrent pneumonia (HP:0006532) | 1.97447899 |
98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.97431760 |
99 | Arterial thrombosis (HP:0004420) | 1.97376498 |
100 | Hyperacusis (HP:0010780) | 1.95822967 |
101 | Sepsis (HP:0100806) | 1.93834234 |
102 | Abnormality of macrophages (HP:0004311) | 1.93393047 |
103 | Lower limb hyperreflexia (HP:0002395) | 1.93051131 |
104 | Thyroiditis (HP:0100646) | 1.91645069 |
105 | Gingivitis (HP:0000230) | 1.91194195 |
106 | Macroorchidism (HP:0000053) | 1.90147954 |
107 | Eosinophilia (HP:0001880) | 1.89627891 |
108 | 11 pairs of ribs (HP:0000878) | 1.89016438 |
109 | Autoimmune hemolytic anemia (HP:0001890) | 1.88654854 |
110 | Deep palmar crease (HP:0006191) | 1.85980395 |
111 | Pustule (HP:0200039) | 1.84639971 |
112 | * Recurrent lower respiratory tract infections (HP:0002783) | 1.83052405 |
113 | Chronic obstructive pulmonary disease (HP:0006510) | 1.83038067 |
114 | Obstructive lung disease (HP:0006536) | 1.83038067 |
115 | Gastrointestinal infarctions (HP:0005244) | 1.81423646 |
116 | Abnormality of male internal genitalia (HP:0000022) | 1.80930156 |
117 | Plagiocephaly (HP:0001357) | 1.80324680 |
118 | Recurrent otitis media (HP:0000403) | 1.80264171 |
119 | * Hepatitis (HP:0012115) | 1.80178658 |
120 | Spastic diplegia (HP:0001264) | 1.79653015 |
121 | Abnormality of eosinophils (HP:0001879) | 1.79065092 |
122 | Progressive muscle weakness (HP:0003323) | 1.78579890 |
123 | Prominent nose (HP:0000448) | 1.78396851 |
124 | Hypergammaglobulinemia (HP:0010702) | 1.78150478 |
125 | Subacute progressive viral hepatitis (HP:0006572) | 1.77926503 |
126 | Hypoplasia of the thymus (HP:0000778) | 1.76591839 |
127 | Skin ulcer (HP:0200042) | 1.76346933 |
128 | Acute hepatic failure (HP:0006554) | 1.76199964 |
129 | Menorrhagia (HP:0000132) | 1.75508745 |
130 | Myocardial infarction (HP:0001658) | 1.72932883 |
131 | Abnormality of the gastric mucosa (HP:0004295) | 1.72722731 |
132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71943227 |
133 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71943227 |
134 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71943227 |
135 | Spondylolisthesis (HP:0003302) | 1.71616943 |
136 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.70884570 |
137 | Mucopolysacchariduria (HP:0008155) | 1.70884570 |
138 | Arthralgia (HP:0002829) | 1.67028725 |
139 | Aortic aneurysm (HP:0004942) | 1.66951219 |
140 | Lymphoma (HP:0002665) | 1.66671734 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRPF4B | 3.69480851 |
2 | MAP4K1 | 3.59849328 |
3 | MAP3K13 | 3.55121408 |
4 | SMG1 | 3.30116243 |
5 | MAP3K14 | 2.79795290 |
6 | JAK3 | 2.71258588 |
7 | EEF2K | 2.49213171 |
8 | ERN1 | 2.40363876 |
9 | TYK2 | 2.35932013 |
10 | KIT | 2.33885021 |
11 | CAMK1D | 2.29913365 |
12 | MAP3K10 | 2.22485663 |
13 | RIPK4 | 2.20542021 |
14 | IKBKE | 2.03383807 |
15 | JAK1 | 2.00935951 |
16 | CAMK1G | 2.00448400 |
17 | TAOK3 | 1.92840438 |
18 | SIK2 | 1.85657742 |
19 | TBK1 | 1.82870610 |
20 | BTK | 1.82002391 |
21 | CDK8 | 1.75425353 |
22 | FGFR4 | 1.75053838 |
23 | FLT3 | 1.71743419 |
24 | NME2 | 1.65604752 |
25 | SYK | 1.63781260 |
26 | PTK6 | 1.62242440 |
27 | IKBKB | 1.60939415 |
28 | EPHA3 | 1.60856378 |
29 | IRAK4 | 1.56033880 |
30 | CHUK | 1.51648904 |
31 | ZAP70 | 1.47294369 |
32 | EPHB1 | 1.43017731 |
33 | LRRK2 | 1.40214430 |
34 | NLK | 1.38826021 |
35 | MAP2K3 | 1.37217587 |
36 | CSF1R | 1.32537067 |
37 | FGFR3 | 1.31768949 |
38 | SRPK1 | 1.31396017 |
39 | CDK12 | 1.30005823 |
40 | MAP3K7 | 1.27488564 |
41 | SIK1 | 1.26570633 |
42 | TRIB3 | 1.25143308 |
43 | TAOK2 | 1.22295844 |
44 | TEC | 1.17661080 |
45 | MAPK15 | 1.15793598 |
46 | HIPK2 | 1.15185304 |
47 | ICK | 1.14969679 |
48 | EIF2AK3 | 1.14730186 |
49 | STK10 | 1.14353546 |
50 | ITK | 1.11038447 |
51 | MAP3K9 | 1.10667485 |
52 | GRK6 | 1.10409080 |
53 | CDK7 | 1.09110019 |
54 | TGFBR2 | 1.08766610 |
55 | HCK | 1.08448614 |
56 | FES | 1.08328198 |
57 | MAPK11 | 1.08214681 |
58 | IRAK3 | 1.07995152 |
59 | CSK | 1.07887856 |
60 | LCK | 1.01444184 |
61 | TAOK1 | 0.99286028 |
62 | RPS6KA4 | 0.98543352 |
63 | PKN2 | 0.97019369 |
64 | JAK2 | 0.94511230 |
65 | PIM1 | 0.87867007 |
66 | RET | 0.87578647 |
67 | PRKD2 | 0.85271557 |
68 | ATR | 0.83878256 |
69 | MAP3K8 | 0.83181401 |
70 | TESK2 | 0.82572624 |
71 | TGFBR1 | 0.78017898 |
72 | CDC7 | 0.76172349 |
73 | PDGFRB | 0.76132783 |
74 | CDK9 | 0.76101888 |
75 | IRAK1 | 0.75509462 |
76 | BLK | 0.72975868 |
77 | LYN | 0.71662732 |
78 | ALK | 0.71216427 |
79 | BMPR2 | 0.69181297 |
80 | CAMKK2 | 0.68775627 |
81 | FGR | 0.68229807 |
82 | MATK | 0.67329692 |
83 | PIK3CG | 0.66350161 |
84 | PRKCH | 0.63772943 |
85 | PDK1 | 0.63484645 |
86 | SCYL2 | 0.63206456 |
87 | MARK3 | 0.61949933 |
88 | MAP3K1 | 0.61337790 |
89 | NEK9 | 0.60944425 |
90 | TNK2 | 0.56742837 |
91 | RPS6KC1 | 0.56347361 |
92 | RPS6KL1 | 0.56347361 |
93 | MARK2 | 0.56019923 |
94 | PRKCQ | 0.55907234 |
95 | LATS1 | 0.55508533 |
96 | CDC42BPA | 0.55480951 |
97 | CDK4 | 0.52655159 |
98 | CDK6 | 0.52000240 |
99 | STK3 | 0.50835399 |
100 | PRKAA2 | 0.50470394 |
101 | CHEK1 | 0.49724128 |
102 | BRD4 | 0.46935231 |
103 | DYRK1B | 0.46477919 |
104 | TXK | 0.46007135 |
105 | TTK | 0.45259081 |
106 | TAF1 | 0.44060337 |
107 | PASK | 0.43628510 |
108 | EIF2AK1 | 0.42188656 |
109 | IRAK2 | 0.41878015 |
110 | MAPKAPK2 | 0.41310608 |
111 | BCKDK | 0.39567679 |
112 | CAMKK1 | 0.38344877 |
113 | DMPK | 0.37764471 |
114 | MELK | 0.37464088 |
115 | RPS6KA6 | 0.37442099 |
116 | STK11 | 0.37207468 |
117 | STK4 | 0.37095122 |
118 | DYRK3 | 0.36945804 |
119 | RPS6KB2 | 0.36922791 |
120 | AURKB | 0.36870241 |
121 | MAPK12 | 0.36525755 |
122 | GRK1 | 0.34641637 |
123 | MST1R | 0.34413158 |
124 | ABL1 | 0.34365550 |
125 | RPS6KA5 | 0.34080121 |
126 | MTOR | 0.33417667 |
127 | PIM2 | 0.32254842 |
128 | EGFR | 0.32011371 |
129 | SIK3 | 0.31588883 |
130 | WNK1 | 0.31447146 |
131 | CLK1 | 0.30011316 |
132 | KSR2 | 0.29830231 |
Rank | Gene Set | Z-score |
---|---|---|
1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.24604477 |
2 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.07257496 |
3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.91258439 |
4 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 2.91192062 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30438235 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09492206 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01054430 |
8 | DNA replication_Homo sapiens_hsa03030 | 1.99772977 |
9 | Measles_Homo sapiens_hsa05162 | 1.83040091 |
10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.70177578 |
11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.69962588 |
12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69497065 |
13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.68537918 |
14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.66485502 |
15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.64307008 |
16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.62216771 |
17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61765043 |
18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.60833057 |
19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.53253009 |
20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52767998 |
21 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.50655257 |
22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.49880333 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49041684 |
24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48758194 |
25 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.48539020 |
26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48160916 |
27 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45041707 |
28 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.43380543 |
29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.37277464 |
30 | Base excision repair_Homo sapiens_hsa03410 | 1.36063875 |
31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.34804214 |
32 | Spliceosome_Homo sapiens_hsa03040 | 1.34250602 |
33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.33615436 |
34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32128906 |
35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.31999906 |
36 | Hepatitis B_Homo sapiens_hsa05161 | 1.29170859 |
37 | Influenza A_Homo sapiens_hsa05164 | 1.28255650 |
38 | Platelet activation_Homo sapiens_hsa04611 | 1.27832237 |
39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26467140 |
40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21237056 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16995394 |
42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15230029 |
43 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12707044 |
44 | Apoptosis_Homo sapiens_hsa04210 | 1.09901425 |
45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06789949 |
46 | Insulin resistance_Homo sapiens_hsa04931 | 1.01736948 |
47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00667486 |
48 | Mismatch repair_Homo sapiens_hsa03430 | 1.00113353 |
49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99857707 |
50 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.99445313 |
51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98305846 |
52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95035436 |
53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94982077 |
54 | Allograft rejection_Homo sapiens_hsa05330 | 0.94413108 |
55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93139598 |
56 | * Tuberculosis_Homo sapiens_hsa05152 | 0.91930121 |
57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89968835 |
58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89271165 |
59 | Glioma_Homo sapiens_hsa05214 | 0.89016118 |
60 | Cell cycle_Homo sapiens_hsa04110 | 0.87173756 |
61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86800400 |
62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.86166097 |
63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85066937 |
64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84874138 |
65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84831982 |
66 | Legionellosis_Homo sapiens_hsa05134 | 0.83513999 |
67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83402716 |
68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81179889 |
69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80752419 |
70 | Hepatitis C_Homo sapiens_hsa05160 | 0.80646305 |
71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79861706 |
72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.78914496 |
73 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.78645910 |
74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77202436 |
75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76630479 |
76 | RNA transport_Homo sapiens_hsa03013 | 0.76547092 |
77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76476575 |
78 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.76327207 |
79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76097458 |
80 | Bladder cancer_Homo sapiens_hsa05219 | 0.76011671 |
81 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75558660 |
82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72217336 |
83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72031516 |
84 | Pertussis_Homo sapiens_hsa05133 | 0.70886783 |
85 | ABC transporters_Homo sapiens_hsa02010 | 0.70840222 |
86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70257762 |
87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70026724 |
88 | Lysine degradation_Homo sapiens_hsa00310 | 0.69654118 |
89 | Shigellosis_Homo sapiens_hsa05131 | 0.67600535 |
90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66858525 |
91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66703762 |
92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.66467167 |
93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.66226616 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66186074 |
95 | Malaria_Homo sapiens_hsa05144 | 0.65800633 |
96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64578330 |
97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62497236 |
98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62157880 |
99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61026138 |
100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60442496 |
101 | Amoebiasis_Homo sapiens_hsa05146 | 0.60038540 |
102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58818883 |
103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57659348 |
104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57335037 |
105 | Ribosome_Homo sapiens_hsa03010 | 0.56942616 |
106 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56765332 |
107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56377696 |
108 | Prostate cancer_Homo sapiens_hsa05215 | 0.55698189 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54869453 |
110 | Asthma_Homo sapiens_hsa05310 | 0.54629436 |
111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54363495 |
112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53952139 |
113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53628069 |
114 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53402965 |
115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51927184 |
116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51778228 |
117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50397326 |
118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49396375 |
119 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.48983959 |
120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48465967 |
121 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48033715 |
122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47824605 |
123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46732361 |
124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46067834 |
125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45493210 |
126 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43813673 |
127 | Phagosome_Homo sapiens_hsa04145 | 0.43399301 |
128 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.41842722 |
129 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41729751 |
130 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41456815 |
131 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41326556 |
132 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.40138834 |
133 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37887859 |
134 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37285347 |
135 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36372729 |
136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35923243 |